Danielle Antin-Ozerkis, MD

Associate Professor of Medicine (Pulmonary)

Physician Biography

There are many forms of interstitial lung disease (ILD), which is sometimes called pulmonary fibrosis. The evaluation, when you come to our clinic, focuses on determining what type of lung disease you have. Once we do this, we can establish an individualized treatment plan. Treatment may include medications but also focuses on exercise, nutrition, oxygen (when necessary), and quality of life.

Specific forms of ILD that we see include: idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated ILD (including lung disease related to rheumatoid arthritis, scleroderma/ systemic sclerosis, dermatomyositis and polymyositis, Sjogren's syndrome, and lupus), as well as sarcoidosis, hypersensitivity pneumonitis and other forms of occupational lung disease.

We have a multidisciplinary program with specialists in pulmonology, radiology, pathology, occupational medicine and rheumatology. Cases are discussed in our group weekly with a goal of finding the correct diagnosis and determining the most appropriate treatment plan. We offer clinical trial enrollment for interested patients and have several open trials for patients with idiopathic pulmonary fibrosis and scleroderma lung disease.

Clinical Interests

  • Connective Tissue Diseases
  • Lung Diseases
  • Pulmonary Fibrosis
  • Sarcoidosis
  • Lung Diseases, Interstitial

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians

Patient Care Organizations

Internal Medicine: Pulmonary, Critical Care & Sleep Medicine: Interstitial Lung Disease Program; Winchester Chest Clinic

Yale Medical Group

Office of Cooperative Research

Board Certifications

  • Critical Care Medicine (Internal Medicine) AB of Internal Medicine (2006)

Clinical Trials

Conditions Study Title
Diseases of the Lung, Diseases of the Respiratory System, Diseases of the Respiratory Systems A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
Diseases of the Respiratory System, Diseases of the Respiratory Systems A Phase 2 Trial to Evaluate the Efficacy of PRM-151 in Subjects with Idiopathic Pulmonary Fibrosis
Diseases of the Respiratory Systems (GB28547) Lebrikizumab
Diseases of the Respiratory Systems (FG-3019-067) Evaluate the Safety and Efficacy of FG-3019 in Patients with IPF

Edit this profile

Contact Info

Danielle Antin-Ozerkis, MD
Patient Care Locations
Winchester Chest ClinicFitkin Memorial Pavilion
789 Howard Avenue, Ste 2nd Floor

New Haven, CT 06519
View on map...
Yale Pulmonary & Critical Care MedicineYale-New Haven Hospital
20 York Street

New Haven, CT 06510
View on map...
Office Locations
Academic OfficeLippard Laboratory of Clinical Investigation (LLCI)
15 York Street, Ste 101B

New Haven, CT 06510
View on map...
Winchester Chest ILD Outpatient ClinicFitkin Memorial Pavilion
789 Howard Avenue

New Haven, CT 06519
View on map...
Mailing Address
PO Box 208057
15 York Street

New Haven, CT 06520-8057